Andrew Retter serves as Executive at VOLITIONRX LTD, where they oversee executive responsibilities. Since joining the company, Andrew Retter has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 1, 2025 involved selling 4,588 shares valued at $2.0K.
Andrew Retter currently holds 146,568 shares of VOLITIONRX LTD (VNRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Retter has been a net neutral trader of VNRX stock. They have purchased $0 and sold $0 worth of shares.
Andrew Retter's most recent insider trade was on Nov 1, 2025, when they sold 4,588 shares at $0.43 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 1, 2025 | VNRX | $3.9K | Payment | 6,142 | $0.64 | Discretionary |
| Jul 1, 2025 | VNRX | $3.4K | Payment | 4,401 | $0.77 | Discretionary |
| Sep 1, 2024 | VNRX | $0 | Award | 9,784 | $N/A | Discretionary |
| Jun 1, 2024 | VNRX | $0 | Award | 8,326 | $N/A | Discretionary |
| May 23, 2024 | VNRX | $0 | Award | 100,000 | $N/A | Discretionary |